Neoleukin Therapeutics Inc (USD)
NLTX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range7.03 | 8.08
52-Wk Range2.00 | 8.55
Last Close7.96
Mkt Cap (m)305.13
Dividend yield-
ISINUS64049K1043
Volume642,238
Exchange VenueNAS

Company Profile

Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology.

Key Information
Price/Earning-
Price/Book4.56
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -130.50
Net Margin %-126.34
Return on Equity-36.82
Debt/Equity0.00

Legal Documents

Prospectus
en 20/01/2017
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)25
Operating Income (m)-9-22-21-38-51-33
Net Income (m)-9-24-22-37-50-32
Basic EPS-1.59-2.75-1.73-1.96-2.14-1.34
Avg. Diluted Shares Outstanding (m)6913192324
Balance Sheet
USD201320142015201620172018
Current Assets (m)15397510310977
Non Current Assets (m)239512
Total Assets (m)164111315411078
Current Liabilities (m)35510115
Total Liabilities (m)------
Total Equity (m)11361081459973
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-8-18-20-30-45-32
Capital Expenditure (m)-1
Figures are quoted in USD unless stated otherwise
-0.19 (-2.39%)
$
7.77
Last Price